Gene · 51441
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| circCNN2 drives endometrial cancer progression through ALKBH5/YTHDF2-mediated m6A regulation and miR-615-5p sponging. | Life Sci | 2026 | 41314596 | PubTator, text mining | PubMed |
| The Tumor-to-Endothelial Transfer of FTO Promotes Vascular Remodeling and Metastasis in Nasopharyngeal Carcinoma. | Adv Sci (Weinh) | 2026 | 41311280 | PubTator, text mining | PubMed |
| Periprosthetic osteolysis is mediated by the m6A-dependent regulation of CEMIP via YTHDF2. | Int Immunopharmacol | 2026 | 41308363 | PubTator, text mining | PubMed |
| Pseudane V alleviates ox-LDL-induced macrophage M1 polarization by inhibiting m6A modification of PPARGC1A. | Exp Cell Res | 2026 | 41297622 | PubTator, text mining | PubMed |
| METTL3 inhibits LINC00312 to suppress osteoporosis progression in a YTHDF2‑dependent manner. | Int J Mol Med | 2026 | 41268604 | PubTator, text mining | PubMed |
| Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function. | J Exp Med | 2026 | 41196643 | PubTator, text mining | PubMed |
| Novel long noncoding RNA lnc_2217 regulates zygotic genome activation through miR-877-3p/YTHDF2 pathway in goat. | Theriogenology | 2026 | 41110214 | PubTator, text mining | PubMed |
| RNA m6A methylation regulates CDH6 to promote epithelial-to-mesenchymal transition in cholangiocytes of biliary atresia. | J Pediatr Surg | 2026 | 40774478 | PubTator, text mining | PubMed |
| RBM15/YTHDF2-mediated m6A modification of HTR1D exacerbates hypoxia-induced dysfunction in trophoblast cells in preeclampsia. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 40719893 | PubTator, text mining | PubMed |
| O-GlcNAcylation of YTHDF2 antagonizes ERK-dependent phosphorylation and inhibits lung carcinoma. | Fundam Res | 2025 | 41613430 | PubTator, text mining | PubMed |
| Machine learning-based comprehensive analysis of m6A RNA methylation regulators in colorectal cancer: implications for prognosis, immune microenvironment, and immunotherapy response. | Exp Biol Med (Maywood) | 2025 | 41613364 | PubTator, text mining | PubMed |
| Homoharringtonine suppresses acute myeloid leukemia progression by orchestrating EWSR1 phase separation in an m6A-YTHDF2-dependent mechanism. | Imeta | 2025 | 41472850 | PubTator, text mining | PubMed |
| Fbxo2 suppresses prostate cancer progression by regulating YTHDF2 ubiquitination and degradation. | Cell Death Dis | 2025 | 41461633 | PubTator, text mining | PubMed |
| Epigenetics of glaucoma in the trabecular meshwork. | Clin Epigenetics | 2025 | 41422257 | PubTator, text mining | PubMed |
| Association of the YTHDF2 rs3738067 A>G variant with hepatoblastoma risk: a multicenter case-control study in Chinese children. | BMC Cancer | 2025 | 41408219 | PubTator, text mining | PubMed |
| Decoding m6A readers: roles of YTHDF proteins in leukemogenesis and cancer immunity. | Front Immunol | 2025 | 41403953 | PubTator, text mining | PubMed |
| Prognostic potential of N6-methyladenosine methylation-associated genes in lung adenocarcinoma. | Transl Cancer Res | 2025 | 41378023 | PubTator, text mining | PubMed |
| YTHDF2 enhances proliferation and metastasis of nasopharyngeal carcinoma by mediating m6A modification in destabilizing FOXO1 mRNA. | Cancer Biol Ther | 2025 | 41369154 | PubTator, text mining | PubMed |
| DAZAP1 promotes cancer progression and chemotherapy resistance by stabilizing PIN1 protein in gastric cancer. | Cell Biol Toxicol | 2025 | 41331184 | PubTator, text mining | PubMed |
| Niclosamide suppresses gastric cancer progression through YTHDF2 inhibition-affected lactate metabolic reprogramming. | iScience | 2025 | 41323282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51441/papers?page=9